Skip to main content

Table 7 Other clinical outcomes

From: Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study

  GROUP A GROUP B GROUP C p value
(n = 52) (n = 53) (n = 52)
Days on insulin treatment 7.1 (2.8) 7.9 (3.2) 7.7 (3.9) 0.41
Days on enteral nutrition 10.5 (7.1) 8.8 (6.7) 9.7 (7.4) 0.39
Days on mechanical ventilation 7 (4–13) 6 (2–11) 6 (3–12) 0.53
ICU stay (days) 13 (9–20) 12 (7–21) 11.5 (7.5–18) 0.42
Hospital stay (days) 27 (18–50) 25 (17–51) 30.5 (14–46.5) 0.98
28-day mortality (N and %) 11 (21.1 %) 10 (18.87) 13 (25 %) 0.73
6-month mortality (N and %) 16 (30.7 %) 20 (37.74) 18 (34.62) 0.71
Δ SOFA −0.37 −0.28 −0.33 0.42
Δ Triglycerides +0.02 −0.21 +0.12 0.18
Δ HOMA2 IR −0.17 −0.01 −0.22 0.76
Δ HOMA2 % S +0.17 +0.09 +0.12 0.89
Δ HOMA2 β-cell +0.21 +0.12 +0.09 0.81
  1. Values are provided as mean (SD), median (Q1-Q3) and percentages (%)
  2. ICU intensive care unit, N number, Δ delta baseline-ICU discharge, SOFA Sequential Organ Failure Assessment, HOMA2, Homeostasis Model Assessment, IR insulin resistance, %S insulin sensitivity, %B beta cell function